| Original language | English |
|---|---|
| Pages (from-to) | 559-561 |
| Number of pages | 3 |
| Journal | The Lancet Oncology |
| Volume | 18 |
| Issue number | 5 |
| DOIs |
|
| Publication status | Published - May 1 2017 |
ASJC Scopus subject areas
- Oncology
Cite this
Ceresoli, G. L., & Mantovani, A. (2017). Immune checkpoint inhibitors in malignant pleural mesothelioma. The Lancet Oncology, 18(5), 559-561. https://doi.org/10.1016/S1470-2045(17)30191-2
Immune checkpoint inhibitors in malignant pleural mesothelioma. / Ceresoli, Giovanni Luca; Mantovani, Alberto.
In: The Lancet Oncology, Vol. 18, No. 5, 01.05.2017, p. 559-561.Research output: Contribution to journal › Comment/debate
Ceresoli, GL & Mantovani, A 2017, 'Immune checkpoint inhibitors in malignant pleural mesothelioma', The Lancet Oncology, vol. 18, no. 5, pp. 559-561. https://doi.org/10.1016/S1470-2045(17)30191-2
Ceresoli GL, Mantovani A. Immune checkpoint inhibitors in malignant pleural mesothelioma. The Lancet Oncology. 2017 May 1;18(5):559-561. https://doi.org/10.1016/S1470-2045(17)30191-2
@article{c96e617db95045c185bce43f492b17dc,
title = "Immune checkpoint inhibitors in malignant pleural mesothelioma",
author = "Ceresoli, {Giovanni Luca} and Alberto Mantovani",
year = "2017",
month = "5",
day = "1",
doi = "10.1016/S1470-2045(17)30191-2",
language = "English",
volume = "18",
pages = "559--561",
journal = "The Lancet Oncology",
issn = "1470-2045",
publisher = "Lancet Publishing Group",
number = "5",
}
TY - JOUR
T1 - Immune checkpoint inhibitors in malignant pleural mesothelioma
AU - Ceresoli, Giovanni Luca
AU - Mantovani, Alberto
PY - 2017/5/1
Y1 - 2017/5/1
UR - http://www.scopus.com/inward/record.url?scp=85018742787&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85018742787&partnerID=8YFLogxK
U2 - 10.1016/S1470-2045(17)30191-2
DO - 10.1016/S1470-2045(17)30191-2
M3 - Comment/debate
AN - SCOPUS:85018742787
VL - 18
SP - 559
EP - 561
JO - The Lancet Oncology
JF - The Lancet Oncology
SN - 1470-2045
IS - 5
ER -